{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:39:11Z","timestamp":1771378751412,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["Mayo Clinic Pharmacy Services Discretionary Funds"],"award-info":[{"award-number":["Mayo Clinic Pharmacy Services Discretionary Funds"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s40262-016-0368-5","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T09:42:01Z","timestamp":1455270121000},"page":"971-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Single-Dose Crossover Pharmacokinetic Comparison Study of Oral, Rectal and Topical Quetiapine in Healthy Adults"],"prefix":"10.1007","volume":"55","author":[{"given":"Jonathan G.","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie L.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia H.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William V.","family":"Bobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross A.","family":"Dierkhising","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Plevak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Lapid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"issue":"3","key":"368_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.12788\/j.suponc.0010","volume":"11","author":"AM Weiland","year":"2013","unstructured":"Weiland AM, Protus BM, Kimbrel J, Grauer PA, Hirsh J. Chlorpromazine bioavailability from a topical gel formulation in volunteers. J Support Oncol. 2013;11(3):144\u20138.","journal-title":"J Support Oncol."},{"issue":"3","key":"368_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jpainsymman.2012.12.002","volume":"45","author":"D Fischberg","year":"2013","unstructured":"Fischberg D, Bull J, Casarett D, Hanson LC, Klein SM, Rotella J, et al. Five things physicians and patients should question in hospice and palliative medicine. J Pain Symptom Manage. 2013;45(3):595\u2013605.","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"368_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jpainsymman.2011.05.017","volume":"43","author":"TJ Smith","year":"2012","unstructured":"Smith TJ, Ritter JK, Poklis JL, Fletcher D, Coyne PJ, Dodson P, et al. ABH gel is not absorbed from the skin of normal volunteers. J Pain Symptom Manage. 2012;43(5):961\u20136.","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"368_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0278-5846(00)00090-7","volume":"24","author":"PT Thyrum","year":"2000","unstructured":"Thyrum PT, Wong YW, Yeh C. Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24(4):521\u201333.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"368_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/01.JGP.0000196628.12010.35","volume":"14","author":"PN Tariot","year":"2006","unstructured":"Tariot PN, Schneider L, Katz IR, Mintzer JE, Street J, Copenhaver M, et al. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. Am J Geriatr Psychiatry. 2006;14(9):767\u201376.","journal-title":"Am J Geriatr Psychiatry."},{"issue":"5","key":"368_CR6","doi-asserted-by":"publisher","first-page":"R215","DOI":"10.1186\/cc10450","volume":"15","author":"JW Devlin","year":"2011","unstructured":"Devlin JW, Skrobik Y, Riker RR, Hinderleider E, Roberts RJ, Fong JJ, et al. Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study. Crit Care. 2011;15(5):R215.","journal-title":"Crit Care"},{"key":"368_CR7","doi-asserted-by":"crossref","unstructured":"de Boer AG, Moolenaar F, de Leede LG, Breimer DD. Rectal drug administration: clinical pharmacokinetic considerations. Clin Pharmacokinet. 1982;7(4):285\u2013311.","DOI":"10.2165\/00003088-198207040-00002"},{"issue":"3","key":"368_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","volume":"9","author":"JD Bos","year":"2000","unstructured":"Bos JD, Meinardi MMHM. The 500\u00a0dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165\u20139.","journal-title":"Exp Dermatol"},{"key":"368_CR9","unstructured":"Bramwell BL, Williams LA. The use of Pluronic lecithin organogels in the transdermal delivery of drugs. Int J Pharm Compd. 2012;16(1):62\u20133."},{"key":"368_CR10","unstructured":"Quetiapine [package insert]. Wilmington: AstraZeneca Pharmaceuticals LP; 2013."},{"key":"368_CR11","unstructured":"Haloperidol [package insert]. Morgantown: Mylan Pharmaceuticals Inc.; 2011."},{"key":"368_CR12","unstructured":"Chlorpromazine [package insert] Morgantown: Mylan Pharmaceuticals Inc.; 2013."},{"key":"368_CR13","unstructured":"Bassani ASP, Banov DM, Lehman PAM. Evaluation of the percutaneous absorption of promethazine hydrochloride, in\u00a0vitro, using the human ex\u00a0vivo skin model. Int J Pharm Compd. 2008;12(3):270\u20133."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-016-0368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-016-0368-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-016-0368-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-016-0368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T22:28:26Z","timestamp":1589668106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-016-0368-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1007\/s40262-016-0368-5","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]},"assertion":[{"value":"12 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This project was supported by Grant Number UL1\u00a0TR000135 from the US National Center for Advancing Translational Science. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the US National Institutes of Health (NIH). This study was also partially funded by a research grant from Mayo Clinic Pharmacy Services Discretionary Funds.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Jonathan G. Leung, Sarah Nelson, Julie L. Cunningham, Virginia H. Thompson, William V. Bobo, Simon Kung, Ross A. Dierkhising, Matthew F. Plevak and Maria I. Lapid have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}